Table 1. Summary of the recommendations for future research discussed during the BILGENSA Research Network to address the female genital schistosomiasis (FGS) and male genital schistosomiasis (MGS) research needs and priorities in endemic settings.
Research need | Recommendations for future research | |
---|---|---|
FGS | MGS | |
Raising awareness and
knowledge |
Provide further training to healthcare workers
and patients on etiology, transmission, symptoms, screening, and management |
Develop and disseminate educational
and training material |
Improving diagnostic
capabilities |
Validate and implement decentralized and field-
deployable screening and diagnostic strategies for community-based surveillance at scale. Evaluate the scalability and cost-effectiveness of different screening and diagnostic strategies |
Develop and validate accessible,
scalable, and low-cost molecular test. |
Developing standardized
treatment guidelines |
Conduct randomized control trials (RCTs) to evaluate the effectiveness of praziquantel for FGS
and MGS Develop and implement FGS/MGS specific treatment guidelines. |
|
Integration of SRH
screening strategies |
Evaluate the integration of FGS within the wider
schistosomiasis and SRH control guidelines. |
Identify potential opportunities for
integration of MGS into ongoing HIV interventions |
Surveillance and
monitoring |
Develop routine and integrated surveillance of FGS
Increase collaborative efforts and financial resources available to implement and expand FGS and MGS control strategies. |